Seung Yeon Lee, Anh Thi Ngoc Bui, Jin Song Park, Gi Ho Lee, Jeonghwan Maeng, Seung-Hwa Baek, Hwi-yeol Yun, Eun Hee Han, Seokwoo Lee, Hye Gwang Jeong
Caffeic acid phenethyl ester (CAPE), a dietary phenolic compound derived from propolis, exhibits cardiovascular and anti-inflammatory effects; however, its mechanisms in endothelial cells remain unclear. In this study, we demonstrated that CAPE induces eNOS phosphorylation and NO production in TNF-α-stimulated endothelial cells. Mechanistically, CAPE-induced NO production is mediated by Akt, PKA, and ERK signaling pathways. In silico docking and pharmacological inhibition confirmed that CAPE directly engages the β2-adrenergic receptor (β2AR) to activate the Gαs/cAMP/Epac axis. Moreover, CAPE suppresses NF-κB activation and inflammatory cytokine expression through NO-dependent mechanisms. Ex vivo studies using aortic rings further validated that CAPE stimulates eNOS activation and NO production via β2AR/Gαs signaling. Collectively, these findings indicate that CAPE enhances endothelial function and exerts anti-inflammatory effects through the β2AR-mediated signaling, highlighting its potential as a therapeutic candidate for endothelial dysfunction and inflammation-related cardiovascular diseases.
* THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS IS NOT INTENDED TO DIAGNOSE, TREAT CURE OR PREVENT ANY DISEASE.